A Consultant Colorectal Surgeon, Mr Aneel Bhangu, says Lagos will soon become a leading hub for Surgical Site Infection (SSI) in Africa to curtail the cause of morbidity and mortality.
Bhangu, who works with the University of Birmingham, UK, spoke with the Nigeria News Agency on the sidelines of a symposium on FALCONS Trials at Oriental Hotel, Lagos.
NAN reports that FALCON Trials is a research aim at reducing infection after surgery.
According to an online publication, Surgical Site Infection (SSI) is any infection originating in surgical wounds or the organs/spaces opened or manipulated during an operative procedure, and it is the most common postoperative complication.
Bhangu said: “Lagos will become one of the most preeminent surgical research hubs, not only for West Africa, but the whole of Africa.
“I think they will become one of the highest volume recruiters in research trials, which will make them hugely influential on the global platform.
“The symposium brings together the first time a unique network of senior surgeons who can reach across Nigeria to bring the patients into trials.
“It is fantastic to see the network of representatives that present the needs of hospitals in Nigeria.’’
According to him, today, we have been talking about our first two trials, Cheetah and FALCON trials. These are both test measures to tackle SSI.
“The whole trials is open in Nigeria and already in Lagos, which has the highest recruiting centre globally. I predict that the Nigeria network will be the lead centre globally.
“We are also working with a research centre in Ghana and I think together that will make a very powerful collaboration in West Africa,’’ he said.
Bhangu said he had been working for more than five years on the trials, but his first time of visiting Nigeria, adding that the FALCONS research trials would be based on tackling SSI.
Also, Dr Adesoji Ademuyiwa, a National Coordinator and Investigator, FALCONS trials in Nigeria, said that the trial was aimed at reducing infection after surgery.
Ademuyiwa, also an Associate Professor of Surgery, University College of Medicine, said that FALCONS trials stem from the previous studies that had been done across the globe based on high impact wounds.
He said that SSI was a serious cause of morbidity and mortality in high and low income countries.
The coordinator said that search through study, which looked at over 12, 000 patients from around the world, documented privilege rate of SSI.
He said that it was nine per cent in high income countries, 14 per cent in low income countries and 23 per cent in low income countries.
Ademuyiwa said that the FALCON trials was an intervention study to reduce SSI which would be looking at the way surgeons prepare the skin before the first cut and the way the wound was closed.
He said that the trials wanted to know which of the techniques would result in the least SSI. (NAN)
Edited by Olagoke Olatoye